Biodesix, Inc.
BDSX
$16.66
$1.449.46%
NASDAQ
| 03/31/2026 | 12/31/2025 | ||||
|---|---|---|---|---|---|
| Revenue | -11.13% | 32.10% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -11.13% | 32.10% | |||
| Cost of Revenue | -5.62% | 18.83% | |||
| Gross Profit | -12.25% | 35.18% | |||
| SG&A Expenses | 5.61% | 5.79% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 4.65% | 6.63% | |||
| Operating Income | -235.50% | 72.09% | |||
| Income Before Tax | -95.80% | 54.34% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | -95.80% | 54.34% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -95.80% | 54.34% | |||
| EBIT | -235.50% | 72.09% | |||
| EBITDA | -798.10% | 89.73% | |||
| EPS Basic | -63.55% | 57.53% | |||
| Normalized Basic EPS | -71.85% | 57.51% | |||
| EPS Diluted | -63.55% | 57.53% | |||
| Normalized Diluted EPS | -71.85% | 57.51% | |||
| Average Basic Shares Outstanding | 19.73% | 7.53% | |||
| Average Diluted Shares Outstanding | 19.73% | 7.53% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||